Sidahmed, E., Freedland, S. J., Wang, M., Wu, K., Albanes, D., Barnett, M., van den Brandt, P. A., Cook, M. B., Giles, G. G., Giovannucci, E., Haiman, C. A., Larsson, S. C., Key, T. J., Loftfield, E., Männistö, S., McCullough, M. L., Milne, R. L., Neuhouser, M. L., Platz, E. A., … Smith-Warner, S. A. (2024). Dietary Fiber Intake and Risk of Advanced and Aggressive Forms of Prostate Cancer: A Pooled Analysis of 15 Prospective Cohort Studies. Journal of the Academy of Nutrition and Dietetics. https://doi.org/10.1016/j.jand.2024.04.006

Zhang, F., Sahu, V., Peng, K., Wang, Y., Li, T., Bala, P., Aitymbayev, D., Sahgal, P., Schaefer, A., Der, C. J., Ryeom, S., Yoon, S., Sethi, N., Bass, A. J., & Zhang, H. (2024). Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut, 73(8), 1280–1291. https://doi.org/10.1136/gutjnl-2023-329686

Lee Argov, E. J., Rodriguez, C. B., Agovino, M., Schmitt, K. M., Desperito, E., Karr, A. G., Wei, Y., Terry, M. B., & Tehranifar, P. (2024). Screening mammography frequency following dense breast notification among a predominantly Hispanic/Latina screening cohort. Cancer Causes & Control, 35(8), 1133–1142. https://doi.org/10.1007/s10552-024-01871-7

Vadivel, C. K., Willerslev-Olsen, A., Namini, M. R. J., Zeng, Z., Yan, L., Danielsen, M., Gluud, M., Pallesen, E. M. H., Wojewoda, K., Osmancevic, A., Hedebo, S., Chang, Y.-T., Lindahl, L. M., Koralov, S. B., Geskin, L. J., Bates, S. E., Iversen, L., Litman, T., Bech, R., … Buus, T. B. (2024). Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome. Blood, 143(15), 1496–1512. https://doi.org/10.1182/blood.2023021671

Wasko, U. N., Jiang, J., Dalton, T. C., Curiel-Garcia, A., Edwards, A. C., Wang, Y., Lee, B., Orlen, M., Tian, S., Stalnecker, C. A., Drizyte-Miller, K., Menard, M., Dilly, J., Sastra, S. A., Palermo, C. F., Hasselluhn, M. C., Decker-Farrell, A. R., Chang, S., Jiang, L., … Olive, K. P. (2024). Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature, 629(8013), 927–936. https://doi.org/10.1038/s41586-024-07379-z

Jamison, J. K., May, M. S., Raufi, A. G., Luk, L., Wong, W., Mundi, P. S., & Manji, G. A. (2024). A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX. The Oncologist, 29(4), 350–355. https://doi.org/10.1093/oncolo/oyad315

Lichtenstein, M. R. L., Levit, L. A., Schenkel, C., Kirkwood, K., Fashoyin-Aje, L. A., Bruinooge, S. S., Kelley, M. J., Mailman, J. A., Magnuson, A., Mirda, D. P., Natesan, D., & Hershman, D. L. (2023). Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials. The Oncologist, 29(4), 356–363. https://doi.org/10.1093/oncolo/oyad237

Gilbertson, R. J., Behjati, S., Böttcher, A.-L., Bronner, M. E., Burridge, M., Clausing, H., Clifford, H., Danaher, T., Donovan, L. K., Drost, J., Eggermont, A. M. M., Emerson, C., Flores, M. G., Hamerlik, P., Jabado, N., Jones, A., Kaessmann, H., Kleinman, C. L., Kool, M., … Pfister, S. M. (2024). The Virtual Child. Cancer Discovery, 14(4), 663–668. https://doi.org/10.1158/2159-8290.cd-23-1500

Wu, C., Cai, X., Wang, Y., Rodriguez, C. D., Zoaldi, G., Herrmann, L., Huang, C.-Y., Wang, X., Sanghvi, V. R., Lu, R. O., & Meng, Z. (2024). Interplay of RAP2 GTPase and the cytoskeleton in Hippo pathway regulation. Journal of Biological Chemistry, 300(5), 107257. https://doi.org/10.1016/j.jbc.2024.107257

Beauchemin, M. P., Solomon, S., Michaels, C. L., McHenry, K., Turi, E., Khurana, R., & Sanabria, G. (2024). Toward identification and intervention to address financial toxicity and unmet health‐related social needs among adolescents and emerging adults with cancer and their caregivers: A cross‐cultural perspective. Cancer Medicine, 13(8). Portico. https://doi.org/10.1002/cam4.7197

Ross, A. B., Gorhe, D., Kim, J. K., Hodapp, S., DeVine, L., Chan, K. M., Chio, I. I. C., Jovanovic, M., & Ayres Pereira, M. (2024). Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO. Cell Reports Methods, 4(5), 100760. https://doi.org/10.1016/j.crmeth.2024.100760

Llanos, A. A. M., Fong, A. J., Ghosh, N., Devine, K. A., O’Malley, D., Paddock, L. E., Bandera, E. V., Hudson, S. V., Evens, A. M., & Manne, S. L. (2022). COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors. Journal of Cancer Survivorship, 18(2), 439–449. https://doi.org/10.1007/s11764-022-01236-6

Zogopoulos, G., Haimi, I., Sanoba, S. A., Everett, J. N., Wang, Y., Katona, B. W., Farrell, J. J., Grossberg, A. J., Paiella, S., Klute, K. A., Bi, Y., Wallace, M. B., Kwon, R. S., Stoffel, E. M., Wadlow, R. C., Sussman, D. A., Merchant, N. B., Permuth, J. B., Golan, T., … __. (2024). The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. Journal of the National Comprehensive Cancer Network, 22(3), 158–166. https://doi.org/10.6004/jnccn.2023.7097

Steffani, M., Geng, Y., Pajvani, U. B., & Schwabe, R. F. (2024). Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis. Journal of Clinical Investigation, 134(7). https://doi.org/10.1172/jci179710

Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., Loda, M., Klocker, H., Rubin, M. A., Zheng, T., Benson, M. C., McKiernan, J. M., Dutta, A., & Abate-Shen, C. (2024). Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. European Urology, 85(4), 361–372. https://doi.org/10.1016/j.eururo.2023.07.016

Rappaport, A. R., Kyi, C., Lane, M., Hart, M. G., Johnson, M. L., Henick, B. S., Liao, C.-Y., Mahipal, A., Shergill, A., Spira, A. I., Goldman, J. W., Scallan, C. D., Schenk, D., Palmer, C. D., Davis, M. J., Kounlavouth, S., Kemp, L., Yang, A., Li, Y. J., … Jooss, K. (2024). A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nature Medicine, 30(4), 1013–1022. https://doi.org/10.1038/s41591-024-02851-9

Ko, K.-P., Zhang, S., Huang, Y., Kim, B., Zou, G., Jun, S., Zhang, J., Zhao, Y., Martin, C., Dunbar, K. J., Efe, G., Rustgi, A. K., Nakagawa, H., Zhang, H., Liu, Z., & Park, J.-I. (2024). Tumor niche network-defined subtypes predict immunotherapy response of esophageal squamous cell cancer. IScience, 27(5), 109795. https://doi.org/10.1016/j.isci.2024.109795

Liu, M., Hu, S., Yan, N., Popowski, K. D., & Cheng, K. (2024). Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity. Nature Nanotechnology, 19(4), 565–575. https://doi.org/10.1038/s41565-023-01580-3

COLOMBO, P. C., CASTAGNA, F., ONAT, D., WONG, K. Y., HARXHI, A., HAYASHI, Y., FRIEDMAN, R. A., PINSINO, A., LADANYI, A., MEBAZAA, A., JELIC, S., ARRIGO, M., LEJEMTEL, T. H., PAPAPANOU, P., SABBAH, H. N., SCHMIDT, A. M., YUZEFPOLSKAYA, M., & DEMMER, R. T. (2024). Experimentally Induced Peripheral Venous Congestion Exacerbates Inflammation, Oxidative Stress, and Neurohormonal and Endothelial Cell Activation in Patients With Systolic Heart Failure. Journal of Cardiac Failure, 30(4), 580–591. https://doi.org/10.1016/j.cardfail.2023.07.016

Georgieva, D., Wang, N., Taglialatela, A., Jerabek, S., Reczek, C. R., Lim, P. X., Sung, J., Du, Q., Horiguchi, M., Jasin, M., Ciccia, A., Baer, R., & Egli, D. (2024). BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks. Cell Reports, 43(4), 114006. https://doi.org/10.1016/j.celrep.2024.114006

Yuan, H., Kehm, R. D., Daaboul, J. M., Lloyd, S. E., McDonald, J. A., Mu, L., Tehranifar, P., Zhang, K., Terry, M. B., & Yang, W. (2024). Cancer incidence trends in New York State and associations with common population-level exposures 2010–2018: an ecological study. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-56634-w

Lee, K. T., Gonzalez, B. D., Geiss, C., Fulton, H. J., Charles, D., Vadaparampil, S. T., Henry, N. L., Jim, H. S. L., Hershman, D. L., Tworoger, S. S., & Gwede, C. K. (2024). Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-024-01574-7

Wang, Z., Yang, X., Chen, D., Liu, Y., Li, Z., Duan, S., Zhang, Z., Jiang, X., Stockwell, B. R., & Gu, W. (2024). GAS41 modulates ferroptosis by anchoring NRF2 on chromatin. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-46857-w

Nolan, N. D., Cui, X., Robbings, B. M., Demirkol, A., Pandey, K., Wu, W.-H., Hu, H. F., Jenny, L. A., Lin, C.-S., Hass, D. T., Du, J., Hurley, J. B., & Tsang, S. H. (2024). CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa. Cell Reports Medicine, 5(4), 101459. https://doi.org/10.1016/j.xcrm.2024.101459

Damoci, C. B., Merrill, J. R., Sun, Y., Lyons, S. K., & Olive, K. P. (2024). Addressing Biological Questions with Preclinical Cancer Imaging. Cold Spring Harbor Perspectives in Medicine, a041378. https://doi.org/10.1101/cshperspect.a041378

Fojo, T., LaRose, M., & Bates, S. E. (2024). The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype. The Oncologist, 29(4), 275–277. https://doi.org/10.1093/oncolo/oyae042

Tzaridis, T., & Wechsler-Reya, R. J. (2024). Just a spoonful of metformin helps the medicine go down. Journal of Clinical Investigation, 134(6). https://doi.org/10.1172/jci179144

Arriaga, J. M., Ronaldson-Bouchard, K., Picech, F., Nunes de Almeida, F., Afari, S., Chhouri, H., Vunjak-Novakovic, G., & Abate-Shen, C. (2024). In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. Oncogene, 43(17), 1303–1315. https://doi.org/10.1038/s41388-024-02995-5

Ben-Ami, R., Wang, Q.-L., Zhang, J., Supplee, J. G., Fahrmann, J. F., Lehmann-Werman, R., Brais, L. K., Nowak, J., Yuan, C., Loftus, M., Babic, A., Irajizad, E., Davidi, T., Zick, A., Hubert, A., Neiman, D., Piyanzin, S., Gal-Rosenberg, O., Horn, A., … Wolpin, B. M. (2023). Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut, gutjnl-2023-331074. https://doi.org/10.1136/gutjnl-2023-331074

Mohan, M., Monge, J., Shah, N., Luan, D., Forsberg, M., Bhatlapenumarthi, V., Balev, M., Patwari, A., Cheruvalath, H., Bhutani, D., Thanendrarajan, S., Dhakal, B., Zangari, M., Al-Hadidi, S., Cooper, D., Lentzsch, S., van Rhee, F., D’Souza, A., Szabo, A., … Chakraborty, R. (2024). Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood Cancer Journal, 14(1). https://doi.org/10.1038/s41408-024-01003-z

Liu, Y., Wang, Y., Feng, H., Ma, L., & Liu, Y. (2024). PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1344058

Mülder, D. T., Hahn, A. I., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., Murphy, J. D., Gutiérrez-Torres, D. S., Zauber, A. G., O’Mahony, J. F., Camargo, M. C., Ladabaum, U., Yeh, J. M., Hur, C., Lansdorp-Vogelaar, I., Meester, R., & Laszkowska, M. (2024). Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 22(8), 1605-1617.e46. https://doi.org/10.1016/j.cgh.2024.02.023

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients. (2024). The American Journal of Managed Care, 30(3), 114–117. Portico. https://doi.org/10.37765/ajmc.2024.89512

Hammons, L., Szabo, A., Janardan, A., Bhatlapenumarthi, V., Annyapu, E., Dhakal, B., Al Hadidi, S., Radhakrishnan, S. V., Narra, R., Bhutani, D., Thanendrarajan, S., Janz, S., Zangari, M., Lentzsch, S., Van Rhee, F., Crescencio, J. C. R., D’Souza, A., Chakraborty, R., Mohan, M., & Schinke, C. (2023). The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. Haematologica, 109(3), 906–914. https://doi.org/10.3324/haematol.2023.283590

Huang, Y., Chan, S. J., Wright, J. D., Kuo, J. H., McManus, C. M., Lee, J. A., & Kuo, E. J. (2024). Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States. Thyroid®, 34(3), 388–398. https://doi.org/10.1089/thy.2023.0651

Su, Z., Liu, Y., Wang, L., & Gu, W. (2024). Regulation of SLC7A11 as an unconventional checkpoint in tumorigenesis through ferroptosis. Genes & Diseases, 101254. https://doi.org/10.1016/j.gendis.2024.101254

Yang, W., & Shaman, J. (2024). Reconciling the efficacy and effectiveness of masking on epidemic outcomes. Journal of The Royal Society Interface, 21(212). https://doi.org/10.1098/rsif.2023.0666

Solfisburg, Q. S., Baldini, F., Baldwin-Hunter, B., Austin, G. I., Lee, H. H., Park, H., Freedberg, D. E., Lightdale, C. J., Korem, T., & Abrams, J. A. (2023). The Salivary Microbiome and Predicted Metabolite Production Are Associated with Barrett’s Esophagus and High-Grade Dysplasia or Adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention, 33(3), 371–380. https://doi.org/10.1158/1055-9965.epi-23-0652

Mellgard, G., Gilligan, M., Cliff, E. R. S., Bhutani, D., Mohyuddin, G. R., Eisenberger, A., Lentzsch, S., & Chakraborty, R. (2024). Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma. HemaSphere, 8(3). Portico. https://doi.org/10.1002/hem3.61

Katsushima, K., Joshi, K., Yuan, M., Romero, B., Batish, M., Stapleton, S., Jallo, G., Kolanthai, E., Seal, S., Saulnier, O., Taylor, M. D., Wechsler-Reya, R. J., Eberhart, C. G., & Perera, R. J. (2024). A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma. Cell Reports, 43(3), 113938. https://doi.org/10.1016/j.celrep.2024.113938

Hu, X., Bukhari, S. M., Tymm, C., Adam, K., Lerrer, S., Henick, B. S., Winchester, R. J., & Mor, A. (2024). Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity. Journal for ImmunoTherapy of Cancer, 12(3), e008482. https://doi.org/10.1136/jitc-2023-008482

Brown, J. R., Ghia, P., Jurczak, W., Kahl, B. S., Lamanna, N., Robak, T., Shadman, M., Tam, C. S., Qiu, L., Paik, J., Salmi, T., Wang, L., Zhang, J., Zhang, M., Cohen, A., Ma, H., & Tedeschi, A. (2024). Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database. Haematologica. https://doi.org/10.3324/haematol.2023.283846

Dai, E., Chen, X., Linkermann, A., Jiang, X., Kang, R., Kagan, V. E., Bayir, H., Yang, W. S., Garcia-Saez, A. J., Ioannou, M. S., Janowitz, T., Ran, Q., Gu, W., Gan, B., Krysko, D. V., Zhu, X., Wang, J., Krautwald, S., Toyokuni, S., … Tang, D. (2024). A guideline on the molecular ecosystem regulating ferroptosis. Nature Cell Biology. https://doi.org/10.1038/s41556-024-01360-8

Zorko, N. A., Makovec, A., Elliott, A., Kellen, S., Lozada, J. R., Arafa, A. T., Felices, M., Shackelford, M., Barata, P., Zakharia, Y., Narayan, V., Stein, M. N., Zarrabi, K. K., Patniak, A., Bilen, M. A., Radovich, M., Sledge, G., El-Deiry, W. S., Heath, E. I., … Antonarakis, E. S. (2024). Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-024-00797-0

Beauchemin, M. P., Ji, L., Williams, A. M., Nightingale, C. L., Dressler, E. V., Salsman, J. M., Santacroce, S. J., Freyer, D. R., Roth, M. E., & Parsons, S. K. (2024). Defining Practice Capacity for Cancer Care Delivery to Adolescents and Young Adults in the Community Setting: 2022 Landscape Assessment Results. Journal of Adolescent and Young Adult Oncology, 13(3), 557–563. https://doi.org/10.1089/jayao.2023.0177

Cheng, X., Henick, B. S., & Cheng, K. (2024). Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles. ACS Nano, 18(9), 6748–6765. https://doi.org/10.1021/acsnano.3c06462

Chen, F., Tang, C., Yang, F., Ekpenyong, A., Qin, R., Xie, J., Momen-Heravi, F., Saba, N. F., & Teng, Y. (2024). HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science Advances, 10(8). https://doi.org/10.1126/sciadv.adk3663

Qiu, B., Zandkarimi, F., Bezjian, C. T., Reznik, E., Soni, R. K., Gu, W., Jiang, X., & Stockwell, B. R. (2024). Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell, 187(5), 1177-1190.e18. https://doi.org/10.1016/j.cell.2024.01.030

Chen, J., Terry, M. B., Dalerba, P., Hur, C., Hu, J., & Yang, W. (2024). Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United States. International Journal of Cancer, 154(11), 1930–1939. Portico. https://doi.org/10.1002/ijc.34887

Hasselluhn, M. C., Decker-Farrell, A. R., Vlahos, L., Thomas, D. H., Curiel-Garcia, A., Maurer, H. C., Wasko, U. N., Tomassoni, L., Sastra, S. A., Palermo, C. F., Dalton, T. C., Ma, A., Li, F., Tolosa, E. J., Hibshoosh, H., Fernandez-Zapico, M. E., Muir, A., Califano, A., & Olive, K. P. (2023). Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Cancer Discovery, 14(2), 348–361. https://doi.org/10.1158/2159-8290.cd-23-0240